Is a complete LON/0ILL research report available?

No complete published report is available for lon/0ILL (LON/0ILL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

lon/0ILL stock profile: metrics, valuation and analysis

Market cap	2.5B
Revenue (ttm)	665.7M
Net income (ttm)	159.5M
EPS (ttm)	€3.12
P/E (trailing)	15.8x
P/E (forward)	19.6x
Dividend	€0.67 (1.31%)
Volume	1,938
Beta	0.23

All LON/0ILL indicators

Market & fundamental data

Available fields

241

Groups with data

Currency

EUR

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	UK
Employees	2,470
Employees Change	51%
Employees Change Percent	2.56
Enterprise value	EUR 2.5B
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	18.72
Industry PE Fwd	15.17
Isin	ES0157261019
Last refreshed	2026-09-11
Market cap	EUR 2.5B
Price	EUR 57.93
Price currency	EUR
Rev Per Employee	269,496.98x
Sector	Healthcare
Sector PE	20.62
Sector PE Fwd	13.37
Sic	2834
Symbol	lon/0ILL
Website	https://www.rovi.es

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.32%
EV Earnings	15.8x
EV/EBIT	19.41x
EV/EBITDA	16.04x
EV/FCF	16.31x
EV/Sales	3.79x
FCF yield	6.12%
Forward P/E	19.59x
P/B ratio	4.09x
P/E ratio	15.82x
P/S ratio	3.79x
PE Ratio10 Y	30.31x
PE Ratio3 Y	22.88x
PE Ratio5 Y	20.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.51%
EBITDA Margin	22.76%
FCF margin	23.26%
Gross margin	64.73%
Gross Profit	EUR 430.9M
Gross Profit Growth	7.06%
Gross Profit Growth Q	25.02%
Gross Profit Growth3 Y	-0.21%
Gross Profit Growth5 Y	12.38%
Net Income	EUR 159.5M
Net Income Growth	40%
Net Income Growth Q	246.65%
Net Income Growth Qo Q	691.19%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	-0.09%
Net Income Growth5 Y	17.56%
Pretax Margin	30.43%
Profit Margin	23.95%
Profit Per Employee	EUR 64,557
Profitable Quarters	EUR 55
Profitable Years	14
ROA	9.44
Roa5y	15.81
ROCE	17.74
ROE	28.65
Roe5y	31.03
ROIC	16.95
Roic5y	30.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	16.89%
Cagr15y	19.17%
Cagr1y	-1.23%
Cagr3y	5.4%
Cagr5y	1.66%
Div CAGR10	21.31%
Div CAGR3	-9.49%
Div CAGR5	11.52%
EPS Growth	39.93
EPS Growth Q	246.7
EPS Growth Quarters	1
EPS Growth Years	1
EPS Growth3 Y	1.32
EPS Growth5 Y	19.45
FCF Growth	138.23%
FCF Growth Qo Q	997.29%
FCF Growth3 Y	42.67%
FCF Growth5 Y	11.11%
OCF Growth	85.51%
OCF Growth Q	785.65%
OCF Growth Qo Q	527.39%
OCF Growth10 Y	20.79%
OCF Growth3 Y	28.03%
OCF Growth5 Y	11.16%
Revenue Growth	3.21x
Revenue Growth Q	20.02x
Revenue Growth Qo Q	25.69x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-1.87x
Revenue Growth5 Y	8.3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.77
Assets	EUR 970.5M
Cash	EUR 110.3M
Current Assets	EUR 488M
Current Liabilities	EUR 237.6M
Debt	EUR 92.7M
Debt EBITDA	EUR 0.59
Debt Equity	EUR 0.15
Debt FCF	EUR 0.6
Equity	EUR 617.4M
Interest Coverage	37.8
Liabilities	EUR 353M
Long Term Assets	EUR 482.5M
Long Term Liabilities	EUR 115.4M
Net Cash	EUR 17.6M
Net Cash By Market Cap	EUR 0.7
Net Debt EBITDA	EUR -0.12
Net Debt Equity	EUR -0.03
Net Debt FCF	EUR -0.11
Tangible Book Value	EUR 572.6M
Tangible Book Value Per Share	EUR 11.2
WACC	5.43

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.05
Inventory Turnover	0.91
Net Working Capital	EUR 164M
Quick ratio	1.04
Working Capital	EUR 250.9M
Working Capital Turnover	EUR 2.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.05%
Dividend Growth	2.6%
Dividend Growth Years	0%
Dividend per share	EUR 0.67
Dividend Years	19
Dividend Yield	1.31%
Ex Div Date	2026-07-13
Last Dividend	EUR 0.78
Payout Frequency	Annual
Payout Ratio	25.83%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	376.25%
1Y total return	-1.23%
200-day SMA	66.98
3Y total return	17.1%
50-day SMA	58.05
50-day SMA vs 200-day SMA	50under200
5Y total return	8.59%
All Time High	93.9
All Time High Change	-38.29%
All Time High Date	2024-05-27
All Time Low	4.75
All Time Low Change	1,120%
All Time Low Date	2012-02-09
ATR	1.33
Beta	0.23
Ch YTD	-8.67
High	58.05
High52	87.5
High52 Date	2026-04-21
High52ch	-33.8%
Low	56.95
Low52	52.45
Low52 Date	2026-07-17
Low52ch	10.45%
Ma50ch	-0.17%
Price vs 200-day SMA	-13.48%
RSI	41.73
RSI Monthly	45.25
RSI Weekly	41.97
Sharpe ratio	-0.05x
Sharpe Ratio3y	0.2x
Sharpe Ratio5y	0.12x
Sortino ratio	0.11
Sortino Ratio3y	0.43
Sortino Ratio5y	0.32
Total Return	1.26%
Tr YTD	-7.38
Tr15y	1,288.47%
Tr1m	-0.43%
Tr1w	-2.52%
Tr3m	2.02%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16,202,605%
Net Borrowing	-23,728,499.3
Shares Institutions	14.33%
Shares Yo Y	0.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	3,207.2x
Bv Per Share	11.8
CAPEX	EUR -63.7M
Ch10y	328.9
Ch15y	1,036.3
Ch1m	-0.43
Ch1w	-2.52
Ch1y	-2.6
Ch3m	0.61
Ch3y	12.73
Ch5y	0.61
Ch6m	-27.84
Change	0.4%
Change From Open	0.4
Close	57.7
Days Gap	0
Depreciation Amortization	21,582,220.1
Dollar Volume	112,266.3
Earnings Date	2026-11-05
EBIT	EUR 129.9M
EBITDA	EUR 151.5M
EPS	EUR 3.12
F Score	6
FCF	EUR 154.5M
FCF EV Yield	6.13x
Financing CF	-62,301,446
Fiscal Year End	December
Founded	1,946
Goodwill	2,321,555.7
Graham Number	34.16931
Graham Upside	-41.02
Income Tax	EUR 43.2M
Investing CF	-86,320,306
Is Primary Listing	0
Last Earnings Date	2026-07-23
Last Report Date	2026-06-30
Lynch Fair Value	EUR 64.27
Lynch Upside	10.94
Ma150	67.19
Ma150ch	-13.75%
Ma20	59.45
Ma20ch	-2.52%
Net CF	69,622,316
Next Earnings Date	2026-11-05
Open	57.7
P FCF Ratio	16.34
P OCF Ratio	11.57
Payment Date	2026-07-15
Position In Range	89
Ppne	417,261,411.3
Price Date	2026-09-10
Price EBITDA	EUR 16.65
Ptbv Ratio	4.41
Relative Volume	0.6x
Revenue	665,657,541x
Tax By Revenue	6.49x
Tax Rate	21.33%
Tr6m	-26.83%
Volume	1,938
Z Score	7.06

LON/0ILL (LON/0ILL)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0ILL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0ILL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0ILL

Frequently asked questions